This page shows the latest Hansa Biopharma news and features for those working in and with pharma, biotech and healthcare.
AAV-based gene therapy for the treatment of Duchenne muscular dystrophy (DMD), the company’s partner Hansa Biopharma AB (Hansa) announced. ... LGMD). Søren Tulstrup, president and chief executive officer of Hansa, said: "We are very excited about the
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...